Replies to post #501188 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

PW this is from Agenda of the CHMP meeting 15-18 September 2025

3.2.1. Blarcamesine - EMEA/H/C/006475
treatment of Alzheimer’s disease and dementia
Scope: List of outstanding issues Action: For adoption
List of Questions adopted on 25.04.2025.

If you see “Scope: List of Outstanding Issues / Action: For adoption” in the CHMP highlights, that means Clock Stop 2 has been triggered.

You can search the internet to see this is true.